UK & European Life Sciences Academy 2016


October 20, 2016

The European life sciences team at Norton Rose Fulbright invite you to attend their annual Life Sciences Academy.

Guest speakers include representatives from Pfizer, Sandoz, LumiraDx and the ABHI.

With increased regulatory scrutiny, Brexit and technology advances; 2016 has been a turbulent year in the life sciences sector.  Our academy will equip in-house legal teams with the know-how and practicalities of how to deal with these changing times.

We will bring together our own and industry experts (including speakers from Pfizer, Sandoz, LumiraDx and the ABHI) to identify and discuss the top of mind issues for in-house legal teams.  The academy will also feature a panel of GCs from the sector focused on the role of General Counsel & Compliance in risk management, and how to create an ethical culture and reduce risk. There will be ample opportunities for questions and a networking lunch.


Networking breakfast & registration 08:45 - 09:15 All invitees welcome.
Welcome by Chairperson 9:20 – 9:25 Huw Evans, Head of Life Sciences EMEA at Norton Rose Fulbright

Overview: Current issues & risks for in-house legal

Led by our London team and with

Key-note Speaker:
Andrew Davies, Market Access Director, ABHI

9:30 – 9:50

10:00 - 10:20

  1. Current Issues in Pharma, Bio-Tech and the Sector as a whole: the changing legal & regulatory landscape and top of mind risks in the sector, including Brexit
  2. Current Issues in Medical Technology: including conflicts of interest work, regulation and procurement
    Andrew Davies, Market Access Director, ABHI
Coffee break 10:20 – 10:30  

Focus on Innovation:

Led by Sven Jacobs (Germany)

10:40 – 11:00

Digital health & technology

  • Advertisement & communication in a digital environment
  • M-health: Medical apps & wearables
  • Blockchain: Identity schemes, data storage and smart contracts
  • Social media

Focus on Anti-trust:

Led by Marta Giner (France)

11:10 – 11:30

The evolving role of anti-trust

  • The impact of the EC Commission and overall trends in anti-trust
  • Patent settlements
  • M&A transactions and pipeline products


Chaired by Robin Adelstein (Partner in our NY office & ex-North America GC of Sandoz) & featuring
Femke Weijtens (Of Counsel in our Amsterdam office & ex-executive at Royal DSM)

Guest Panellist GCs:

Ruth Coles, Vice President & International Legal Lead EUCANZ,
Pfizer Limited

Barbara Levi Mager, General Counsel & Global Head of Legal,
Sandoz International GmbH

Veronique Ameye, General Counsel,

11:40 – 12:30

In-house Counsel panel discussion

This panel discussion will focus on the role of General Counsel & Compliance in risk management, and how to create an ethical culture and reduce risk.

Representatives from industry will join the panel discussion.

Topics will include:

  • The unique challenges of being a General Counsel and Chief Compliance Officer in the life sciences industry
  • The role of the General Counsel v. Chief Compliance Officer
  • The risks of General Counsel as valued business advisors
  • Ethical leadership and how to effectively model ethical behavior
Networking lunch 12:30 – 13:30 All invitees welcome.


Huw Evans

Huw Evans


Huw Evans is Head of Life Sciences and Healthcare, EMEA and a partner in the London office at Norton Rose Fulbright.

Andrew Davies

Andrew Davies

Market Access Director, Association of British Healthcare Industries

Andrew Davies is Market Access Director at the ABHI. His responsibility is for ensuring that reimbursement, evaluation and adoption mechanisms are aligned and optimized to support access for medical technologies. This entails creating an on going dialogue between industry and policy makers to ensure efficient and effective diffusion structures, processes and methodologies are created and maintained.

Andrew has worked in the Medical Technology sector for over 20 years experience in the medical devices industry having worked within MedTech divisions of household names such as Thorn EMI, Philips and Bristol-Myers Squibb. He has held roles covering UK and international marketing, market access and business development across both capital and consumable equipment.

He has a degree in Applied Physics and a post graduate Diploma in Marketing.

Ruth Coles

Ruth Coles

Vice President & International Legal Lead EUCANZ Pfizer Limited

Ruth hails from the North of England where she started her career in private practice. In 2003, she started her in-house career at Pfizer as a legal adviser in the UK team. Over the last 13 years she has assumed various positions of increasing seniority and she has been International Legal Lead for Europe, Canada, Australia & New Zealand for the last 18 months. Ruth is based in Pfizer’s Surrey office but spends a lot of time on the road, visiting her team and also traveling to New York HQ where the Executive Team meets regularly.


Pam Taak

Pam Taak

Robin Adelstein

Robin Adelstein

New York
Sven Jacobs

Sven Jacobs

Marta Giner Asins

Marta Giner Asins

Paris Casablanca